Israel’s CollPlant (see here) is developing a proprietary rhCollagen-based formulations intended for use as bio-ink for the 3D printing of tissues and life savings organs. It has now received grant approval (up to $1.2 million) of additional finance from the Israel Innovation Authority (IIA).
Go-ahead for bio-ink
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.